Sofiget Tablet 400mg

Sofiget Tablet – Advanced Targeted Antiviral Therapy

Sofiget is a highly specialized antiviral medication containing Sofosbuvir, designed for the treatment of serious chronic viral infections of the liver. It is specifically indicated for the management of chronic hepatitis C (CHC) infection in adult patients. The medication acts as a direct-acting antiviral (DAA), which targets the virus itself to stop it from multiplying within the body's cells. Sofiget is used as a core component of a combination antiviral treatment regimen, which is essential for reaching undetectable viral levels and achieving a cure. By clearing the Hepatitis C virus, it prevents long-term life-threatening complications such as liver cirrhosis, liver failure, and liver cancer. This treatment represents a significant advancement over older therapies, offering significantly higher cure rates and a better tolerance profile for the patient. The 400mg tablet is designed for convenient once-daily oral administration, typically over a course of 12 to 24 weeks. Strict adherence to the full combination regimen is vital to ensure therapeutic success and prevent viral resistance. Sofiget has transformed the outlook for patients with chronic liver disease by providing a highly effective and reliable pathway to viral clearance and restored liver health.

• Indicated for the treatment of chronic hepatitis C (CHC) in adults.
• Direct-acting antiviral that targets viral replication.
• Essential component of combination therapy for a permanent cure.
• Available as: Tablets 400MG.